Clinical Research Directory
Browse clinical research sites, groups, and studies.
EGCG for Hepatocellular Carcinoma Chemoprevention
Sponsor: University of Texas Southwestern Medical Center
Summary
This phase II trial tests epigallocatechin gallate (EGCG) for its efficacy and safety in preventing development of hepatocellular carcinoma (HCC) in patients with liver cirrhosis.
Official title: Phase II Randomized Controlled Trial of Epigallocatechin Gallate for Hepatocellular Carcinoma Chemoprevention
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
60
Start Date
2024-09-01
Completion Date
2028-08-31
Last Updated
2025-09-05
Healthy Volunteers
No
Conditions
Interventions
Epigallocatechin gallate (EGCG)
EGCG is a green tea-derived catechin
Placebo
Placebo in the same capsule with the experimental agent (EGCG).
Locations (1)
UT Southwestern
Dallas, Texas, United States